ANDA 63119, held by Igi Labs Inc. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63119 (Tobramycin Sulfate), held by Igi Labs Inc, was first approved by FDA on Oct 31, 1994, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 10MG BASE/ML ยท injectable;injection | Tobramycin Sulfate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters